Direct-acting antiviral treatment for hepatitis C, reinfection and mortality among people attending an inner-city community health centre in Victoria, Canada
Dados Bibliográficos
| ID | 14907013 |
|---|---|
| Autores | Marion Selfridge (0000-0001-9829-2870, autor correspondente), Evan B Cunningham (0000-0002-8048-3473, UNSW Sydney), Rozalyn Milne, Anne Drost, Tamara Barnett (0009-0003-8001-1235), Karen Lundgren, Kellie Guarasci, J Grebely (0000-0002-1833-2017, UNSW Sydney), Chris Fraser (0000-0003-4611-6589) |
| Ano | 2019 |
| Volume | 72 |
| Páginas | 106-113 |
| Data de publicação | 2019-10-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | International Journal of Drug Policy (JOURNAL) |
| Identificadores do periódico | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editora | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2019.03.001 |
| PMID | 31178254 |
| OpenAlex | W2952982994 |
| Idioma | EN |
| Citações recebidas | 4 |
| Referências citadas | 28 |
Coinfection · Hepatitis C · Hepatitis C virus · Human immunodeficiency virus (HIV · Retrospective cohort study · Virus · Hepatitis B Virus Studies · Hepatitis C virus research · Liver Disease Diagnosis and Treatment · Medicine · Internal Medicine · Pediatrics · Virology
Integrated hepatitis C treatment is associated with improved retention and success in outpatient treatment for opioid use disorder at a private clinic
Elimination of hepatitis C virus infection among people who use drugs
Reinfection following successful direct-acting antiviral therapy for HCV infection among people attending an inner-city community health centre in Victoria, Canada
Hepatitis C reinfection following successful direct-acting antiviral therapy among patients attending a multidisciplinary treatment centre for people who use drugs in Zurich, Switzerland
Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs
Hepatitis C treatment access and uptake for people who inject drugs
Mortality among people who inject drugs
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs
Recommendations for the management of hepatitis C virus infection among people who inject drugs
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy
Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs
Factors associated with lost to follow-up after hepatitis C treatment delivered by primary care teams in an inner-city multi-site program, Vancouver, Canada
Opioid-related mortality in rural America
| Obras citantes distintas | 4 |
|---|---|
| Citações por ano | 0,57 |
| Intervalo de citações | 2019 - 2022 (4) |
| Velocidade de citação | historical |
| Altamente citado | Não |
| Tipos de citação | Neutras: 4 |